Webcast ImageWebcast
Q1 2016 Clovis Oncology, Inc. Earnings Conference Call (Replay)
05/05/16 at 4:30 p.m. ET
Q1 2016 Clovis Oncology, Inc. Earnings Conference Call
Thursday, May 5, 2016 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs target specific subsets of cancer, and we seek to simultaneously develop, with partners, companion diagnostics that direct our product candidates to the patients most likely to benefit from their use. We believe this approach to personalized medicMore >>

Stock Chart
Stock chart for: 03NA000000CLVS
Stock Quote
CLVS (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Up 0.26 (1.58%)
Intraday High$16.75
Intraday Low$15.72
Data as of 05/27/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
05/19/16Clovis Oncology Announces Data Presentations at 2016 ASCO Annual Meeting
New rucaparib data to be highlighted in poster presentations Rolling New Drug Application (NDA) submission for rucaparib for the treatment of patients with advanced ovarian cancer expected to complete during Q2 2016 European Marketing Authorization Application (MAA) planned in Q4 2016 BOULDER, Colo.--(BUSINESS WIRE)--May 19, 2016-- Clovis Oncology, Inc. (NASDAQ: CLVS) today announced its presen... 
Printer Friendly Version 
05/05/16Clovis Oncology Announces Q1 2016 Operating Results and Corporate Update
Rucaparib rolling NDA submission initiated for treatment of patients with advanced ovarian cancer with deleterious BRCA mutated tumors and expected to complete Q2 2016 Rucaparib MAA submission planned Q4 2016 Clovis preparing for potential U.S. commercial launch of rucaparib with existing commercial infrastructure in Q4 2016 or Q1 2017 ARIEL3 pivotal rucaparib maintenance study target enrollment... 
Printer Friendly Version 
04/26/16Clovis Oncology to Announce First Quarter 2016 Financial Results and Host Webcast Conference Call on May 5
BOULDER, Colo.--(BUSINESS WIRE)--Apr. 26, 2016-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2016 financial results on Thursday, May 5, 2016, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the company’s results in greater detail. The conference call is being webcast and can be accessed from the Clovis On... 
Printer Friendly Version 
Upcoming EventsMore >>
There are currently no events scheduled.
Receive Email AlertsEmail Alert Icon
Sign up to receive email alerts whenever Clovis Oncology, Inc. posts new information to the site. Just enter your email address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.